Seeking Alpha

BCRX
  BioCryst Pharmaceuticals, Inc. - NASDAQ

10/31/2014, 9:53 PM ET
  • denewa | Send Message 18 Jan 2013

    zacks rank $BCRX : 1- strong buy
    Reply
      BCRX vs. ETF Alternatives
      Company Description
      Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States